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ABSTRACT
Histology-based grade classification is clinically important
for many cancer types in stratifying patients distinct treatment
groups. In prostate cancer, the Gleason score is a grading
system used to measure the aggressiveness of prostate can-
cer from the spatial organization of cells and the distribution
of glands. However, the subjective interpretation of Glea-
son score often suffers from large interobserver and intraob-
server variability. Previous work in deep learning-based ob-
jective Gleason grading requires manual pixel-level annota-
tion. In this work, we propose a weakly-supervised approach
for grade classification in tissue micro-arrays (TMA) using
graph convolutional networks (GCNs), in which we model
the spatial organization of cells as a graph to better capture
the proliferation and community structure of tumor cells. As
node-level features in our graph representation, we learn the
morphometry of each cell using a contrastive predictive cod-
ing (CPC)-based self-supervised approach. We demonstrate
that on a five-fold cross validation our method can achieve
0.9659 ± 0.0096 AUC using only TMA-level labels. Our
method demonstrates a 39.80% improvement over standard
GCNs with texture features and a 29.27% improvement over
GCNs with VGG19 features. Our proposed pipeline can be
used to objectively stratify low and high risk cases, reducing
inter- and intra-observer variability and pathologist workload.
Index Terms— Gleason Score Grading, Graph Convolu-
tional Networks, Deep Learning, Histopathology Calassifica-
tion, Objective Grading, Patient Stratification
1. INTRODUCTION
The subjective interpretation of histology slides is the standard-
of-care for prostate cancer detection and prognostication. The
commonly used Gleason score, which informs the aggressive-
ness of prostate cancer, is based on the architectural pattern
of tumor tissues and the distribution of glands. Gleason grade
ranges from 1 to 5 to suggest how much the prostate tissue
looks like healthy tissue (lower score) versus abnormal tissue
(higher score). If the glands are small, discrete and uniform,
the Gleason grade is relatively lower. On the contrary, if
the glands are fused or poorly-formed, the Gleason grade is
higher. A primary and a secondary grade which range from
1 to 5 are assigned to prostate tissue and the sum of the two
grades determines the final Gleason score. However, its man-
ual assignment is based on visual, microscopy-based evalu-
ation of cellular and morphological patterns, which can be
extremely error-prone and time-consuming for pathologists
and suffers from interobserver and intraobserver variability
[1]. Deep learning has been widely applied to the detection of
malignancies in histology images [2, 3, 4]. Researchers have
demonstrated that convolutional neural networks (CNNs)
can serve as a tool for automated histology image classifi-
cation [5, 6, 7], including Gleason score assignment, which
alleviates the aforementioned limitations of subjective inter-
pretation. However, CNNs are not sufficiently context-aware
and do not capture the dense spatial relationships between
cells that are predictive of cancer grade and proliferation. In
addition, CNN-based methods require detailed pixel or patch
level annotations which are tedious and time consuming to
curate [8].
On the contrary, graphs are a reasonable and natural op-
tion to model the distribution of the cells in histopathology
images. With the cells as nodes and the edges generated by a
proper algorithm, graphs can accurately capture the distribu-
tion of cells and the spatial relations between the cells. GCN
is a deep learning approach for performing feature extrac-
tion and classification on graphs[9]. In this paper, we pro-
pose a GCN based-approach for automatic patient stratifica-
tion trained using TMA-level labels and node features learned
via a self-supervised technique known as contrastive predic-
tive coding (CPC) [10, 11]. GCNs can learn from the global
distribution of cell nuclei, cell morphometry and spatial fea-
tures without requiring exhaustive pixel-level annotation.
2. RELATED WORK
Objective Gleason score grading: Previous work on
computer-aided Gleason score grading has used machine
learning with pixel-level annotations. Khurd et al. [12] have
developed a texture classification system for automatic and
reproducible Gleason grading. They use random forests to
cluster extracted filter responses at each pixel into basic tex-
ar
X
iv
:1
91
0.
13
32
8v
2 
 [c
s.C
V]
  6
 N
ov
 20
19
ture elements (textons) and characterize the texture in images
belonging to a certain tumor grade. del Toro et al. [13]
stratify the patients into high-risk and low-risk with the deci-
sion boundary of Gleason score 7-8. They train a CNN that
requires pixel-level labels on regions of interests (ROI) ex-
tracted from WSIs and are able to detect prostatectomy WSIs
with highgrade Gleason score. Arvaniti et al. [8] present
a deep learning approach for automated Gleason grading of
prostate cancer TMAs and are able to assign both the primary
score and secondary score to a single pixel in the patients’
TMAs. However, all current methods require pixel or patch
level labels and do not incorporate the spatial organization
of cells to fullt capture the architexture of the tumor micro-
environment.
Classification using GCNs: GCNs proposed by Kipf et al.
[9] has been utilized in many classification tasks. Recently,
Zhou et al. [14] propose using GCN for colorectal cancer
classification, where each node is represented by a nucleus
within the original image and cellular interactions are denoted
as edges between these nodes according to node similarity.
Then they extract spatial features like the centroid coordinates
and texture features like angular second moment (ASM) ob-
tained from grey level co-occurrence matrix (GLCM) [15, 16]
for each nodes. GCNs are utilized to classify each image
into normal, low-grade and high-grade based on the degree
of gland differentiation. Anand et al. [17] also propose to
classify cancers using GCNs by modeling a tissue section as
a multi-attributed spatial graph of its constituent cells. They
not only extract the spatial and texture features but also use
a pre-trained VGG19 model to generate features from a win-
dow of size 71 × 71 around the nuclei centroids. Then, a
GCN is trained on the breast cancer BACH dataset [18] to
classify patients into cancerous or non-cancerous. However,
these methods rely on gray-scale on ImageNet features and
do mot use unsupervised features.
3. METHODS
Our idea is inspired by the process through which pathol-
ogists examine prostate TMAs and assign Gleason scores.
The pathologists inspect the spatial distributions of the glands
in TMAs. In order to model the distribution of the nuclei,
we segment out the nuclei, and then construct the graphs for
TMAs with nuclei as the nodes and the potential connection
between neighbor nuclei as the edges. With the carefully con-
structed cell graphs, we are able to apply GCNs and obtain the
stratification results.
3.1. TMA Graph Construction
In order to capture the information stored in prostate TMAs,
the images first need to be stain-normalized to remove the
color variance. Then, each images is converted to a cell graph
where the nuclei are the nodes and the possible interactions
are the edges. We constructed a graph for each TMA using
the following steps: i) segmenting the nuclei, which form the
set of nodes. ii) modeling interactions between nuclei using
edges. iii) generating features for each node.
Nuclei Segmentation: To detect atypical and packed nuclei
and other features that suggest cancerous tissues, precise seg-
mentation results are fundamental. Fully convolutional neu-
ral networks (FCNN) have been used for nuclei segmenta-
tion in the past, which aims to minimize pixel-wise loss [19].
However, this can sometimes leads to the fusion of nuclei
boundaries and these blurry outlines of nuclei can cause fea-
ture extraction and graph structure construction to be inaccu-
rate. In order detect the nuclei robustly and clearly, we uti-
lize conditional GANs (cGANs) [20]. Such methods, which
use an proper loss function for semantic segmentation, have
been proved to avoid the aforementioned issues. We train our
model for segmentation on the Multi-Organ Nuclei Segmen-
tation dataset [21]. This dataset, which consists of 21,623
nuclei in 30 images, comes from 18 different hospitals and
include diverse nuclear appearances from a variety of organs
like liver, prostate, bladder, etc.
Nuclei Connection: We assume that nuclei that are close to
each other are more likely to have interactions and we intend
to capture the architectural structure between neighboring nu-
clei. Based on this idea, we adopt the K-nearest neighbors
(KNN) algorithm[22], in which each nucleus is connected to
its top 5 nearest neighboring nucleus if they are within a cer-
tain Euclidean distance (100 pixels in our method).
Nuclei Feature Extraction: Based on the nuclei masks ob-
tained using a cGAN, we then extract both morphological
and texture features for each nucleus, along with features ex-
tracted from CPC-based self-supervise learning.
• Morphological Features: For morphological features, we
compute area, roundness, eccentricity, convexity, orienta-
tion, etc for each of the nucleus.
• Texture Features: To analyze the nuclei texture in the
TMAs, we calculate GLCM for each nucleus and then com-
pute second order features like dissimilarity, homogeneity,
energy and ASM based on the obtained GLCM.
• Contrastive Predictive Coding Features: Contrastive
predictive coding is an unsupervised learning approach to
extract useful representations from high-dimensional data.
By predicting the future in the latent space, CPC [11] is
able to learn such representations through autoregressive
models. With a certain data sequence {xt}, a feature net-
work genc first calculates a low-dimensional embedding zt
for each observation. Then, an auto-regressive context net-
work gc can accumulate observations prior to t, namely,
ct = gc({zi}), for i ≤ t. CPC utilizes a contrastive loss,
through which the mutual information shared between the
context ct, the present, and future observations zt+k, k > 0
can be maximized. The network aims to correctly distin-
guish the positive target zt+k from sampled negative can-
didates. Predictions for zt+k can be achieved linearly us-
ing weights Wk: zˆt+k =Wkct. If the probability score for
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Fig. 1. For cell identification nuclei are segmented in each TMA and a graph is built on the centeroid of each nuclei using
the K-nearest neighbours (KNN) algorithm. Morphological, texture and contrastive predictive coding (CPC) features are then
extracted for each nucleus and GCNs are applied on the graph representation. Finally, a fully connected layer is used at the end
for classification.
each candidate zi is assigned through a log-bilinear model,
the CPC objective is just the standard cross-entropy loss for
the positive target. When applying CPC to images, small,
overlapping patches need to be extracted from each image.
We train a CPC encoder on extracted TMA patches of size
256 × 256 and a stride of 128. We then use the trained
model to extract features from a window of size 64 × 64
around the centroid of each detected nucleus.
When applying CPC to prostate TMAs at the scale of 256
× 256 patches, we expect that the context (summarized
from rows of features that are visible to the network) and
unknown future observations (rows of features hidden from
the network) are conditionally dependent on shared high-
level information specific to the underlying pathology and
the tissue site at this resolution. Examples of such high-
level information might include the morphology and dis-
tinct arrangement of different cell types, the tissue texture
and micro-environment, etc. By minimizing the CPC ob-
jective in the latent space, we implicitly encourage learning
of such shared high-level abstractions specific to prostate
tissue, which one is unlikely to effectively capture by us-
ing features extracted through naive transfer learning from
ImageNet.
For each nucleus in a prostate TMA, we generate 8 mor-
phological features, 4 texture features from GLCMs and 1024
features from CPC. Then, we concatenate them together to
form a feature matrix V ∈ RNi×F where Ni is the number of
nuclei in the graph and F is the number of features (1036 in
our method).
3.2. Graph Convolution Networks
While CNNs remain a powerful deep learning tool for med-
ical image analysis, they can only perform on grid-like Eu-
clidean data like 2-dimensional images. Studies have been
exploring how to generalize convolutional networks onto non-
Euclidean domains. Convolution operators have been refined
by Kipf et al. [9] to perform on non-grid-like data as graphs
like protein structure and nuclei distribution. Through mes-
sage passing, each node is able to iteratively accumulate fea-
ture vectors from its neighboring nodes and generate a new
feature vector at the next hidden layer of the network, thus
GCNs can learn to represent for each feature in a node. This
process is very similar to feed-forward networks or CNNs.
Then, by pooling over all the nodes, we are able to achieve
the presentation for the entire graph. Such graph presentation
can then serve as inputs for tasks as graph-level classification.
In our method, we used the GraphSAGE convolution [23].
The convolution and pooling operations can be defined as fol-
lows:
a(k)v = MAX
({
ReLU
(
W · h(k−1)u
)
,∀u ∈ N (v)
})
h(k)v =W ·
[
h(k−1)v , a
(k)
v
]
At the (k − 1)th iteration of the neighborhood accumula-
Table 1. A comparative analysis of prostate TMA classification using various models and features.
Model Accuracy ↑ AUC↑
GCN + GLCM features 0.6299 ± 0.0391 0.6909 ± 0.0240
GCN + GLCM + Transfer Learning (ResNet56) 0.6412 ± 0.0181 0.6987 ± 0.0294
GCN + GLCM + Transfer Learning (VGG19) [17] 0.7194 ± 0.1192 0.7486 ± 0.0377
GCN + GLCM + CPC features (Proposed) 0.8995 ± 0.0222 0.9659 ± 0.0096
tion, the feature vector for node v is denoted by h(k)v while the
feature vector of node v at the next iteration is represented by
a
(k)
v .
For the pooling part, we utilize the self-attention graph
pooling method [24]. Self-attention can reduce computational
complexity and take the topology into account. By perform-
ing self-attention graph pooling, our method is able to cal-
culate attention scores, focus on the more meaningful node
features and aggregate information of nuclei graph topology
on different levels. The attention score Z ∈ RN×1 for nodes
in G can be calculated as follows:
Z = σ
(
SAGEConv
(
X,A+A2
))
The node features are represented by X , the adjacency ma-
trix is suggested by A, while SAGEConv is the convolution
operator from GraphSAGE.
4. EXPERIMENTS AND RESULTS
We train both the CPC and the GCN on a high-resolution
H&E stained image dataset from 5 prostate TMAs, each con-
taining 200-300 spots [25, 26]. There are 886 images in total.
For each image, there is a pixel-level annotation mask sug-
gesting the Gleason scores. In order to obtain the TMA-level
labels, we calculate the primary grade and secondary grade
based on the area in the mask and sum up the two grade to-
gether as the final Gleason score. For data augmentation, we
took 1550 × 1550 crops from the four corners and the center
of each image, and computed their corresponding binary la-
bels. The crops that do not contain tissue are discarded. We
classify the TMAs with Gleason score higher than (including)
6 as high-risk while TMAs with Gleason score lower than 6
as low-risk. Gleason scores of 3 + 3 and 3 + 4 are known
to have the most interobserver and intraobserver variability
[27] and our proposed method can stratify between the two
highly variable scores. We validate our approach on 5 class-
balanced splits where each splits contain 3498 crops for train-
ing, 388 crops for validation and 432 crops for testing. Table
1. shows a comparative analysis of our proposed method with
other methods in a five-fold cross validation.
For comparison, we trained GCNs with the features gen-
erated from GLCMs, ResNet56 and VGG19 in contrast to
the features generated from CPC. Results show GCNs with
a combination of GLCM and CPC features achieve state-of-
the-art results with an AUC of 0.9659.
Fig. 2. Comparative analysis of our approach (GCN with
GLCM+CPC features) as compared to other approaches
demonstrates that our method achieves a 39.80% higher AUC
over GCNs with just GLCM features and a 29.27% improve-
ment over GCNs with VGG19 features. The shade suggests
the confidence interval from the 5 random cross validation
5. CONCLUSIONS
In the paper, we propose an approach for using GCNs as a
tool to stratify patients on prostate cancer. Our approach is
able to accurately identify high-risk patients using the prostate
TMAs with only the image-level labels instead of the pixel-
level labels. Also, we demonstrate that using CPC features in
graph convolution can outperform features generated through
simple transfer learning from ImageNet.
Our deep learning-based TMA stratification pipeline can
be used as an assistive tool for pathologists to automatically
stratify out high-risk cases before review. This work has the
potential to alleviate the overall pathologist burden, acceler-
ate clinical workflows and reduce costs. Future work will in-
volve scaling this to a six class classification problem, iden-
tifying nodes being activated for interpretability and fusing
information from patient and familial histories and incorpo-
rating multi-omics information for improved diagnostic and
prognostic determinations. We will also explore methods to
scale this to whole slide images.
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